Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NY › BUFFALO › KALEIDA HEALTH

KALEIDA HEALTH

NPI: 1639209596 · BUFFALO, NY 14203 · General Acute Care Hospital · NPI assigned 03/07/2007

$30.80M
Total Medicaid Paid
790,874
Total Claims
723,900
Beneficiaries
301
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialMCCROREY, ANGELA (AR MANAGER)
Parent OrganizationKALEIDA HEALTH
NPI Enumeration Date03/07/2007

Related Entities

Other providers sharing the same authorized official: MCCROREY, ANGELA

ProviderCityStateTotal Paid
KALEIDA HEALTH BUFFALO NY $80.65M
KALEIDA HEALTH WILLIAMSVILLE NY $11.67M
KALEIDA HEALTH NORTH TONAWANDA NY $5.40M
KALEIDA HEALTH BUFFALO NY $2K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 973 $54K
2019 43,252 $1.25M
2020 68,174 $2.63M
2021 137,143 $5.26M
2022 178,835 $7.57M
2023 196,754 $7.86M
2024 165,743 $6.17M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
G0378 Hospital observation service, per hour 3,227 3,099 $4.23M
99283 Emergency department visit for the evaluation and management, moderate severity 11,978 11,258 $2.46M
99284 Emergency department visit for the evaluation and management, high severity 12,582 11,943 $2.36M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 12,191 11,556 $1.95M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 17,989 16,616 $1.49M
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12,948 11,974 $1.22M
96361 Intravenous infusion, hydration; each additional hour 5,987 5,557 $1.12M
99282 Emergency department visit for the evaluation and management, low to moderate severity 5,397 4,903 $1.08M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 7,718 7,305 $957K
80053 Comprehensive metabolic panel 63,549 48,976 $929K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,279 1,268 $826K
70450 Computed tomography, head or brain; without contrast material 3,907 3,776 $720K
93458 424 418 $671K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 20,914 20,528 $582K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 20,705 20,376 $506K
74177 Computed tomography, abdomen and pelvis; with contrast material 2,028 1,991 $487K
45380 Colonoscopy, flexible; with biopsy, single or multiple 590 585 $467K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 17,448 17,144 $369K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4,690 4,080 $366K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 13,534 13,475 $351K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 13,186 12,574 $328K
87631 6,212 6,077 $302K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 715 707 $270K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1,752 1,744 $248K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1,772 1,732 $247K
99281 Emergency department visit for the evaluation and management, self-limited or minor 1,147 1,108 $233K
70551 Magnetic resonance imaging, brain; without contrast material 1,122 1,109 $226K
88305 Level IV - Surgical pathology, gross and microscopic examination 4,964 4,625 $223K
87481 3,277 3,241 $199K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 7,355 7,323 $188K
71275 Computed tomographic angiography, chest, with contrast material 903 892 $170K
74176 Computed tomography, abdomen and pelvis; without contrast material 629 625 $162K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,104 1,098 $158K
70496 869 864 $158K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1,303 1,240 $149K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 906 891 $145K
84443 Thyroid stimulating hormone (TSH) 14,138 13,930 $140K
99442 1,200 1,154 $136K
80061 Lipid panel 15,584 15,479 $132K
80048 Basic metabolic panel (calcium, ionized) 12,237 9,667 $128K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4,986 4,953 $128K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 982 975 $127K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 47,800 41,686 $126K
36415 Collection of venous blood by venipuncture 24,748 17,488 $120K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 513 509 $106K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 6,631 6,468 $106K
87086 Culture, bacterial; quantitative colony count, urine 15,392 14,822 $102K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 6,024 5,499 $94K
83880 3,833 3,658 $93K
83036 Hemoglobin; glycosylated (A1C) 11,400 9,761 $90K
84153 4,745 4,716 $82K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 5,588 5,568 $79K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 119 118 $72K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 402 401 $69K
87070 8,551 8,363 $61K
86900 3,559 3,462 $58K
81513 1,976 1,937 $56K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 17,398 16,094 $55K
99443 488 466 $54K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years 385 384 $51K
93975 86 85 $47K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 413 391 $47K
82803 2,300 2,082 $47K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,688 3,569 $45K
97161 1,044 1,019 $43K
82607 3,684 3,662 $43K
84439 5,350 5,299 $43K
81025 11,799 11,367 $43K
97803 2,253 2,243 $43K
96127 4,242 3,221 $39K
87077 4,451 4,313 $37K
71046 Radiologic examination, chest; 2 views 9,084 8,828 $37K
86850 3,540 3,473 $37K
93017 802 798 $36K
86901 3,529 3,432 $35K
86780 3,575 3,516 $35K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk 40 40 $34K
88342 537 529 $31K
86141 3,957 3,021 $31K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1,259 1,213 $31K
86003 476 452 $31K
0042T 587 578 $29K
84403 1,167 1,139 $28K
81001 16,515 15,964 $28K
99406 956 949 $28K
87186 4,068 3,928 $27K
85610 11,359 9,770 $26K
82728 2,178 2,154 $25K
A9577 Injection, gadobenate dimeglumine (multihance), per ml 629 620 $25K
83735 9,296 7,832 $25K
87147 1,680 1,654 $24K
86480 461 454 $24K
82746 2,248 2,236 $24K
83874 7,182 6,614 $22K
85027 6,841 5,551 $22K
87088 3,410 3,339 $22K
C1769 Guide wire 1,348 1,326 $21K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 9,238 8,304 $21K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 5,203 5,049 $18K
86803 2,212 2,200 $17K
82043 3,406 3,392 $16K
76000 428 420 $16K
72125 Computed tomography, cervical spine; without contrast material 627 621 $16K
82570 3,789 3,753 $16K
85730 5,777 5,590 $16K
87660 1,195 1,153 $16K
90715 489 488 $15K
87480 1,197 1,156 $14K
87510 1,193 1,152 $14K
97162 239 235 $14K
83690 5,213 4,951 $14K
C1887 Catheter, guiding (may include infusion/perfusion capability) 94 94 $14K
83540 2,676 2,633 $13K
96375 Therapeutic injection; each additional sequential IV push 5,227 4,764 $12K
83970 270 245 $11K
86762 772 771 $11K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 257 255 $11K
74174 41 41 $11K
82784 667 659 $10K
3077F 466 142 $10K
83550 2,017 1,996 $10K
94726 417 414 $10K
83001 620 616 $10K
70498 591 588 $10K
76705 Ultrasound, abdominal, real time with image documentation; limited 427 421 $10K
90686 315 312 $10K
86769 529 520 $9K
83655 729 721 $9K
83605 3,551 3,263 $9K
71045 Radiologic examination, chest; single view 5,813 5,570 $9K
85651 4,472 3,680 $9K
94729 507 504 $8K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 1,043 1,030 $8K
96376 1,626 1,430 $8K
70486 84 84 $8K
87522 Neg quan hep c or qual rna 201 190 $8K
83002 456 454 $7K
84154 435 430 $7K
84146 424 414 $7K
84702 750 673 $7K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 643 619 $7K
71250 65 65 $7K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes 70 70 $7K
86038 1,006 1,000 $7K
93308 38 38 $6K
3074F 320 103 $6K
84134 737 629 $6K
73564 910 737 $6K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 220 218 $6K
94010 432 413 $6K
82785 401 401 $6K
86706 608 600 $6K
84703 1,913 1,882 $6K
82948 4,310 2,961 $5K
87340 637 631 $5K
84484 9,900 8,881 $5K
99215 Prolong outpt/office vis 38 37 $5K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 14 14 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 124 123 $4K
11721 195 114 $4K
C9399 Unclassified drugs or biologicals 345 344 $4K
99205 Prolong outpt/office vis 29 29 $4K
97802 183 181 $4K
87210 1,304 1,193 $4K
20610 13 13 $4K
86765 319 318 $4K
84550 881 859 $4K
84436 844 841 $3K
86376 244 244 $3K
88304 226 224 $3K
84100 1,194 1,003 $3K
72141 16 16 $3K
84402 127 127 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1,521 1,149 $3K
J2704 Injection, propofol, 10 mg 3,424 3,096 $3K
86735 320 319 $3K
84481 277 277 $3K
85008 367 330 $3K
73030 636 592 $3K
81003 1,886 1,880 $3K
J1050 Injection, medroxyprogesterone acetate, 1 mg 271 270 $3K
87184 496 484 $3K
J2785 Injection, regadenoson, 0.1 mg 79 79 $3K
88112 85 85 $3K
80320 968 937 $3K
76830 Ultrasound, transvaginal 109 107 $3K
86431 533 530 $3K
73502 544 529 $2K
73630 710 647 $2K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 801 794 $2K
82550 909 774 $2K
80348 483 461 $2K
85032 1,340 1,214 $2K
97116 124 95 $2K
86800 165 165 $2K
97165 40 38 $2K
94760 1,233 1,100 $2K
80076 304 303 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete 40 40 $2K
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 235 183 $2K
72100 218 218 $2K
88313 145 142 $2K
77067 Screening mammography, bilateral, including computer-aided detection 26 26 $2K
3075F 55 16 $2K
87040 790 760 $2K
88341 27 27 $2K
73562 243 204 $1K
90688 86 86 $1K
81002 1,023 1,005 $1K
87625 464 462 $1K
99441 32 32 $1K
82565 867 856 $1K
86039 165 162 $1K
83721 389 385 $1K
86787 102 102 $993.01
87181 130 126 $934.02
82150 201 199 $931.70
85018 649 627 $923.37
86618 57 57 $919.35
84480 168 168 $909.21
73610 328 308 $903.97
86696 49 49 $892.09
94060 26 26 $879.78
69210 21 12 $843.81
83993 66 66 $778.88
82670 26 26 $777.03
72110 128 128 $745.71
85379 605 600 $745.11
J1644 Injection, heparin sodium, per 1000 units 2,742 1,659 $641.43
73130 429 404 $594.80
86592 221 221 $565.12
86255 74 46 $526.01
97530 Therapeutic activities, direct patient contact, each 15 minutes 53 38 $515.95
82140 58 48 $504.67
84156 135 129 $489.43
86704 58 57 $480.03
90656 20 20 $421.34
82787 16 16 $357.83
88302 12 12 $327.80
73110 97 90 $322.87
77063 Screening digital breast tomosynthesis, bilateral 26 26 $306.71
86738 13 13 $294.70
J3010 Injection, fentanyl citrate, 0.1 mg 2,869 2,768 $291.91
74018 31 28 $237.06
87075 50 50 $219.98
84460 41 40 $199.69
89190 37 37 $183.68
84450 38 37 $182.94
J2250 Injection, midazolam hydrochloride, per 1 mg 2,875 2,817 $167.88
J2270 Injection, morphine sulfate, up to 10 mg 1,254 1,068 $157.62
87081 58 55 $151.82
J0690 Injection, cefazolin sodium, 500 mg 1,417 1,270 $140.13
82950 27 27 $133.65
J1170 Injection, hydromorphone, up to 4 mg 2,054 1,576 $132.10
85347 25 24 $125.29
82977 24 24 $121.95
87338 13 13 $116.35
87400 297 264 $113.60
J2405 Injection, ondansetron hydrochloride, per 1 mg 4,365 3,841 $104.92
80361 21 21 $97.87
J1885 Injection, ketorolac tromethamine, per 15 mg 4,293 3,921 $89.20
J0330 Injection, succinylcholine chloride, up to 20 mg 219 217 $88.76
87101 25 25 $86.82
86710 255 252 $84.17
85045 31 27 $70.33
80177 12 12 $69.70
82248 13 12 $60.60
83615 15 12 $58.10
J3370 Injection, vancomycin hcl, 500 mg 96 83 $57.01
87430 246 245 $55.36
84520 12 12 $47.94
73590 31 29 $45.52
J0696 Injection, ceftriaxone sodium, per 250 mg 1,000 851 $44.75
J3475 Injection, magnesium sulfate, per 500 mg 408 360 $44.22
87449 13 13 $43.86
73080 13 13 $41.80
82010 74 67 $40.14
89051 14 14 $37.46
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,741 1,703 $33.38
87324 12 12 $30.51
82945 12 12 $26.82
84157 12 12 $25.76
J0131 Injection, acetaminophen, not otherwise specified,10 mg 199 197 $23.20
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 40 40 $21.79
74022 24 24 $16.07
J1200 Injection, diphenhydramine hcl, up to 50 mg 969 911 $12.62
J3480 Injection, potassium chloride, per 2 meq 60 50 $9.86
J0780 Injection, prochlorperazine, up to 10 mg 25 24 $8.00
J2765 Injection, metoclopramide hcl, up to 10 mg 657 596 $6.74
J2060 Injection, lorazepam, 2 mg 215 206 $4.03
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 85 83 $2.44
J2305 Injection, nitroglycerin, 5 mg 12 12 $0.26
J2370 Injection, phenylephrine hcl, up to 1 ml 218 214 $0.12
J1171 Injection, hydromorphone, 0.1 mg 75 59 $0.00
C9113 Injection, pantoprazole sodium, per vial 43 26 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 27 26 $0.00
J0744 Injection, ciprofloxacin for intravenous infusion, 200 mg 13 13 $0.00
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml 112 110 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 86 84 $0.00
80329 14 13 $0.00
C2617 Stent, non-coronary, temporary, without delivery system 14 13 $0.00